KURAKura Oncology, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 17862
Ticker: KURA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-08-25
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: KURA

Detail

Enriched 2026-08-14 20:47

Market cap: $882,417,188.1
Shares outstanding (class): 88,774,365
Shares outstanding (weighted): 88,774,365
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 260
Location: SAN DIEGO, CA
Homepage: https://www.kuraoncology.com
Description: Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Market cap and share counts drift.

Funds holding this security

82 funds · 82 positions · $96.52M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$22.17M	0.00%	2,726,738 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$20.51M	0.28%	2,523,230 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$16.00M	0.02%	1,967,638 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$7.92M	0.01%	974,770 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$5.62M	0.05%	691,817 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$5.11M	0.06%	628,449 NS	FIGI
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS	—	$2.44M	0.10%	300,321 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$1.92M	0.05%	236,158 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.24M	0.00%	151,998 NS	FIGI
NVIT Multi-Manager Small Company Fund Nationwide Variable Insurance Trust	—	$1.19M	0.33%	145,981 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.11M	0.02%	137,018 NS	FIGI
SMALL CAP EQUITY FUND GuideStone Funds	—	$1.10M	0.13%	135,479 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$811.8K	0.05%	99,858 NS	FIGI
BlackRock Advantage Small Cap Growth Fund BlackRock Funds	—	$749.2K	0.11%	92,152 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$697.5K	0.02%	85,789 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERKURA
FIGI_COMPOSITEBBG008974342
FIGI_SHARE_CLASSBBG008974351
CIK0001422143
ISINUS50127T1097
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.85
Model: deepseek
Rationale: Kura Oncology is a clinical-stage biopharmaceutical company focused on oncology, fitting the biotechnology industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.